Next-Generation Neurological Testing Platform
Legal Citation
Summary of the Inventive Concept
A comprehensive, AI-driven neurological testing system integrating wearable devices, virtual reality, and cloud-based analytics to provide personalized, real-time assessments and diagnoses.
Background and Problem Solved
The original patent disclosed a performance test system for evaluating neurological function. However, it had limitations in terms of user experience, data analysis, and scalability. The new inventive concept addresses these limitations by introducing a next-generation platform that leverages AI, machine learning, and advanced sensors to provide more accurate and personalized assessments.
Detailed Description of the Inventive Concept
The system consists of a wearable neurological testing device with a neural interface for real-time brain activity monitoring, integrated with a virtual reality platform that utilizes machine learning algorithms to adapt the testing environment to an individual's cognitive and neuromotor abilities. The system also includes a cloud-based platform for remote testing, featuring a secure data storage system and analytics engine, enabling real-time collaboration and data sharing between healthcare professionals and researchers. The modular, 3D-printed platform can be customized to accommodate various neurological and cognitive tests, and includes sensors for tracking user movements and gestures.
Novelty and Inventive Step
The new claims introduce the use of AI, machine learning, and advanced sensors to provide personalized, real-time assessments and diagnoses, which is a significant departure from the original patent's limitations. The integration of wearable devices, virtual reality, and cloud-based analytics is a novel and non-obvious combination that enables a more comprehensive and accurate evaluation of neurological function.
Alternative Embodiments and Variations
Alternative embodiments could include the use of augmented reality instead of virtual reality, or the integration of other types of sensors, such as EEG or EMG. Variations could include the development of specialized testing platforms for specific neurological disorders, or the creation of a mobile app for remote testing and data tracking.
Potential Commercial Applications and Market
The next-generation neurological testing platform has significant commercial potential in the healthcare and medical research industries, particularly in the areas of neurological disorder diagnosis and treatment. The platform's ability to provide personalized, real-time assessments and diagnoses could revolutionize the field of neurological testing, and its potential applications could extend to fields such as education and cognitive training.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B5/7271 |
| A | A61 | A61B3/032 |
| A | A61 | A61B5/11 |
| A | A61 | A61B5/112 |
| A | A61 | A61B5/1124 |
| A | A61 | A61B5/1125 |
| A | A61 | A61B5/16 |
| A | A61 | A61B5/165 |
| A | A61 | A61B5/225 |
| A | A61 | A61B5/4023 |
| A | A61 | A61B5/4076 |
| A | A61 | A61B5/4082 |
| A | A61 | A61B5/4088 |
| A | A61 | A61B5/162 |
| A | A61 | A61B2560/04 |
| A | A61 | A61B2562/0219 |
| G | G06 | G06F2203/04809 |
Original Patent Information
| Patent Number | US 11,857,349 |
|---|---|
| Title | Apparatus and related method to facilitate test via a computing device |
| Assignee(s) | THE CLEVELAND CLINIC FOUNDATION, BIOGEN MA INC. |